Recruiting

Culturally Informed Intervention

Sponsor:

University of Texas, El Paso

Code:

NCT05800899

Conditions

Alcohol Use Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Brief Motivational Interviewing

Culturally adaptation brief motivational interviewing

Study Details

Brief summary:

This Stage II Randomized Efficacy Trial will compare the effectiveness of a theoretically informed and culturally responsive brief motivational intervention to a non-adapted brief intervention among non-treatment seeking Latinxs admitted for medical treatment of an injury who engage in at risk drinking or were drinking at the time of their injury. The culturally informed brief motivational intervention (CI-BMI) increases autonomous motivation to engage in protective drinking behavior and reduce alcohol problems while addressing barriers to help seeking and facilitating treatment utilization. This project will address the alcohol related health disparities and treatment inequities among Latinx who are more likely to experience alcohol problems yet less likely to receive treatment in order to reduce the negative public health impact of alcohol.

Conditions

Alcohol Use Disorder

Study ID

NCT05800899

Start date

Jun 30, 2023

Status verified date

Aug, 2025

Completion date

Jun 30, 2027

Anticipated

Primary completion date

May 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Admission to a level 1 -trauma center
  • Involved in a alcohol-related injury
  • Self-identify as Latinx
  • 18 or older
  • Minimum Blood Alcohol Concentration (BAC) score of .001 and/or at risk drinking

Exclusion Criteria:

  • Traumatic brain injury or otherwise debilitating injury as indicated by a Glasgow Coma Scale score of less than 15.
  • Cognitive impairment as indicated by a score of 24 or less on the Mini-Mental Status Exam

Study Design

Enrollment

600 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

active comparator: Brief Motivational Interviewing

experimental: Culturally Adaptation Brief Motivational Interviewing

Interventions

Brief Motivational Interviewing

Standard non-adapted brief motivational interviewing based on motivational interviewing.

Culturally adaptation brief motivational interviewing

culturally adapted brief motivational interviewing based on motivational interviewing.

Primary outcome measure

  • Change from baseline in protective drinking strategies on 7-point Protective Behavioral Strategies Scale (PBSS) at 3-month [ Time Frame: Baseline and 3 month ]
  • Change from baseline in protective drinking strategies on 7-point Protective Behavioral Strategies Scale (PBSS) at 6-month [ Time Frame: Baseline and 6 month ]
  • Change from baseline in protective drinking strategies on 7-point Protective Behavioral Strategies Scale (PBSS) at 12-month [ Time Frame: Baseline and 12 month ]
  • change from baseline in alcohol problems on a 5-point scale using the Short Index of Problems (SIP) at 3 months [ Time Frame: Baseline and 3 month ]
  • change from baseline in alcohol problems on a 5-point scale using the Short Index of Problems (SIP) at 6 months [ Time Frame: Baseline and 6 month ]
  • change from baseline in alcohol problems on a 5-point scale using the Short Index of Problems (SIP) at 12 months [ Time Frame: Baseline and 12-month ]

Central Contacts and Locations

Central contacts

Locations

University Medical Center of El Paso

Recruiting

El Paso, Texas, United States, 79905

Contacts

More Information

Sponsor

University of Texas, El Paso

Last update posted

Aug 24, 2025

Last verified

Aug, 2025

Keywords

  • Brief Motivational Intervention
  • Cultural Adaptation
  • Mechanisms of Change
  • Self-Determination Theory
  • Harm Reduction
  • Alcohol Use Disorder

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Texas, El Paso on 2025-08-24.